Budesonide nebuliser suspension is indicated for the maintenance treatment and as prophylactic therapy of asthma.

Children 3 months to 12 years of age: 0.5-1 mg twice daily.

Adults and elderly: 1-2 mg twice daily.

Hypersensitivity to any of the ingredients of this preparation.

Sneezing, headache, sore throat, dry mouth, nausea etc. have been reported as the common side effects

Budesonide nebuliser suspension should be used with caution in patients with active or quiescent tuberculous infection, untreated fungal, bacterial, or systemic viral infections, or ocular herpes simplex infection.

Pregnancy & Lactation

Pregnancy: There are no adequate and well-controlled studies in pregnant women. Budesonide nebuliser suspension, like other corticosteroids, should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Lactation: It is not known whether Budesonide is excreted in human milk. Because other corticosteroids are excreted in human milk, caution should be exercised when Budesonide nebuliser suspension is administered to nursing women.